December 10, 2020 — Physicians did not recognize side effects from radiation therapy in more than half of breast cancer patients who reported a significant symptom, a new study finds.

December 10, 2020 — According to an open-access Editor's Choice article in ARRS' American Journal of Roentgenology (AJR), post-neoadjuvant therapy (NAT) changes in metabolic metrics from PET/MRI and morphologic metrics from CT were associated with pathologic response and overall survival in patients with pancreatic ductal adenocarcinoma (PDA).

December 9, 2020 — AiCure, an artificial intelligence (AI) and advanced data analytics company focused on improving clinical trials, introduced AiCure Data Intelligence, its next-generation data dashboard to empower sponsors with advanced visibility into each trial's progress via a single, holistic data hub.

December 9, 2020 — the digital medical technology company, announced today that over 120 systems have been sold around the world leveraging the Mixed Reality Viewer from Brainlab on the Magic Leap spatial computing platform.

December 8, 2020 — After recovering from COVID-19, some patients are left with chronic, debilitating pain, numbness or weakness in their hands, feet, arms and legs due to unexplained nerve damage. A new Northwestern Medicine study shows how advanced imaging technology can pinpoint what may have caused patients' nerve damage and help determine the best course of treatment.

December 8, 2020 — The medical imaging market size has the potential to grow by $17.64 billion during 2020-2024, and the market’s growth momentum will decelerate during the forecast period.

December 8, 2020 — For heavy (ex-)smokers, lung cancer screening using low-dose computed tomography (low-dose CT, LDCT) offers more benefit than harm. The procedure can save a number of people from dying of lung cancer; for some of them, it might also prolong overall survival.

December 8, 2020 — Total medical devices industry deals for Q3 2020 worth $98.5B were announced globally, according to GlobalData’s deals database. The value marked an increase of 1,039.5% over the previous quarter and a rise of 860% when compared with the last four-quarter average of $10.26B.

In terms of number of deals, the sector saw a rise of 15.7% over the last four-quarter average with 508 deals against the average of 439 deals. In value terms, North America led the activity with deals worth $93.96B.

December 7, 2020 — Philips, a global leader in health technology, today announced it will introduce its latest advancements in digital pathology at the European Congress of Pathology 2020 virtual event, Dec. 6-8. Building on its strong portfolio to support oncology clinical decision-making, Philips brings together the power of imaging, pathology, genomics and longitudinal data with insights from artificial intelligence, to empower clinicians to deliver clear care pathways with predictable outcomes for every patient.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now